The U.S. FDA approved Teva Pharmaceutical Industries Ltd.'s Vantrela for pain.
The treatment is formulated with Teva's proprietary abuse-deterrent technology.
US FDA approves Teva Pharmaceutical's pain medication
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits